New 1,2,4-oxadiazole derivatives with positive mGlu4 receptor modulation activity and antipsychotic-like properties-Reference-Cited by-同舟云学术

New 1,2,4-oxadiazole derivatives with positive mGlu4 receptor modulation activity and antipsychotic-like properties

Published:2021-12-11 Issue:1 Volume:37 Page:211-225
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

Stankiewicz Anna¹,Kaczorowska Katarzyna¹^ORCID,Bugno Ryszard¹^ORCID,Kozioł Aneta¹,Paluchowska Maria H.¹^ORCID,Burnat Grzegorz²^ORCID,Chruścicka Barbara²^ORCID,Chorobik Paulina²^ORCID,Brański Piotr²^ORCID,Wierońska Joanna M.²,Duszyńska Beata¹^ORCID,Pilc Andrzej²^ORCID,Bojarski Andrzej J.¹^ORCID

Affiliation:

1. Department of Medicinal Chemistry, Maj Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland

2. Department of Neurobiology, Maj Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14756366.2021.1998022

Reference96 articles.

1. Orthosteric versus allosteric GPCR activation: The great challenge of group-III mGluRs

2. Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors

3. Allosteric Binding Site and Activation Mechanism of Class C G-Protein Coupled Receptors: Metabotropic Glutamate Receptor Family

4. Pharmacology of Metabotropic Glutamate Receptor Allosteric Modulators

5. Allosteric modulation of metabotropic glutamate receptors: Structural insights and therapeutic potential

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting mGluR group III for the treatment of neurodegenerative diseases;Biomedicine & Pharmacotherapy;2023-12

2. Room Temperature Synthesis of Bioactive 1,2,4-Oxadiazoles;International Journal of Molecular Sciences;2023-03-12

3. Clinical investigations of compounds targeting metabotropic glutamate receptors;Pharmacology Biochemistry and Behavior;2022-09